# Zentalis Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Dec 15, 2025

- Company: [Zentalis Pharmaceuticals, Inc.](/companies/zntl.md) (CIK 1725160)
- Form: SCHEDULE 13D/A
- Filed: 2025-12-15
- Accepted by EDGAR: Dec 15, 2025, 17:16 ET
- Period: not reported
- Accession: 0000902664-25-005287
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1725160/000090266425005287/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1725160/000090266425005287/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1725160/000090266425005287/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Dec 15, 2025.
Source: SEC EDGAR, the filing index for accession 0000902664-25-005287. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.